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Histamine Contributes to Tissue Remodeling via
Periostin Expression
Lingli Yang1, Hiroyuki Murota1, Satoshi Serada2, Minoru Fujimoto2, Akira Kudo3, Tetsuji Naka2 and
Ichiro Katayama1
Histamine is thought to have a critical role in the synthesis of extracellular matrix in skin and may be involved in
tissue remodeling of allergic diseases. Recent studies revealed that periostin, a matricelluar protein, contributed
to tissue remodeling; however, a link between periostin and histamine remains unproven. We investigated
whether periostin was involved in histamine-induced collagen production. Cultured dermal fibroblasts derived
from wild-type (WT) or periostin knockout (PN / ) mice were stimulated with histamine, and then collagen and
periostin production was evaluated. Histamine induced collagen gene expression in WT fibroblasts in the late
phase but not in the early phase, whereas no effect on collagen expression was observed in histamine-stimulated
PN / fibroblasts. In WT fibroblasts, histamine directly induced periostin expression in a dose-dependent
manner, and an H1 receptor antagonist blocked both periostin and collagen expression. Histamine activated
extracellular signal-regulated kinase 1/2 (ERK1/2) through the H1 receptor. Periostin induction was inhibited by
either H1 antagonist or ERK1/2 inhibitor treatment in vitro and was attenuated in H1R / mice. Elevated
expression of periostin was found in lesional skin from atopic dermatitis patients. These results suggest that
histamine mediates periostin induction and collagen production through activation of the H1 receptor–mediated
ERK1/2 pathway; furthermore, histamine may accelerate the chronicity of atopic dermatitis.
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INTRODUCTION
Tissue remodeling is both a cause and a consequence of
allergic inflammation and is considered a target for therapeutic
intervention.
Understanding the underlying mechanisms that cause tissue
remodeling is progressing gradually, and certain factors that
are correlated with allergic inflammation have been found to
be involved in tissue remodeling. Among them, histamine
has been found to induce de novo synthesis of collagen
from fibroblasts in both in vivo and in vitro experiments
(Sandberg, 1962, 1964; Cohen et al., 1972; Murota et al.,
2008). Furthermore, it is well known that antihistamine drugs
used for the treatment of allergic disorders improve hyper-
trophic scars (Murakami et al., 1998). These results indicate
that histamine may be involved in the mechanism of tissue
remodeling in allergic diseases; however, it remains unknown
how histamine contributes to tissue remodeling.
Recent studies showed that expression of periostin, a
matricellular protein with profibrogenic function, increased
in sera and lesional tissue from patients with allergic diseases,
such as allergic rhinitis, asthma, and atopic dermatitis (AD),
and that this expression was associated with airway or other
tissue remodeling (Takayama et al., 2006; Hur et al., 2012;
Masuoka et al., 2012). Furthermore, periostin has also
emerged as a key regulator in the development of wound
healing and scleroderma (Ontsuka et al., 2012; Yang et al.,
2012). To the best of our knowledge, the impact of histamine
on the expression level of periostin is unknown. Therefore, in
this study, we investigated the correlation between histamine
and the fibrotic factor periostin in primary cultured dermal
fibroblasts.
RESULTS
Collagen production is induced by histamine stimulation
To investigate whether histamine influences collagen synth-
esis, primary cultured murine dermal fibroblasts were stimu-
lated with histamine at concentrations ranging from 0 to
100mM, as described in our previous report (Murota et al.,
2008; Murota and Katayama, 2009).
Histamine-induced type I collagen production was
observed with concentrations of histamine from 1 to 100mM
(Figure 1). Compared with nontreated controls, collagen
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synthesis was significantly increased after histamine treatment
in a dose-dependent manner (Figure 1a, c and d). No
significant increase was observed at 2 and 12 hours, whereas
collagen was markedly induced by histamine 24 and 48 hours
after addition (Figure 1a and b). In our previous study (Yang
et al., 2012), the mRNA expression of type I collagen was
found to be significantly increased in cultured mouse dermal
fibroblasts after a 2-hour stimulation with recombinant periostin
alone. Therefore, these late responses in the present study may
be a result of de novo synthesis of certain second messengers.
Periostin is upregulated upon histamine stimulation in dermal
fibroblasts
Next, to investigate whether histamine affects the expression
level of periostin, we stimulated wild-type (WT) primary
dermal fibroblasts with histamine at the indicated concentra-
tions (Figure 2). As expected, two hours of incubation with
histamine produced a significant dose-dependent increase of
periostin mRNA expression in dermal fibroblasts, as assessed
by reverse transcriptase–PCR and quantitative real-time
reverse transcriptase–PCR (Figure 2a and b). After 24 hours
of incubation with histamine, the periostin protein levels
increased in the culture supernatant and cell lysates
(Figure 2 c). These results suggest that histamine may directly
upregulate the transcription and synthesis of periostin.
Histamine upregulates periostin expression via histamine
receptor 1 (H1R)
To identify the histamine receptor subtype responsible for the
histamine-induced periostin expression, antagonists for H1R,
H2R, and H4R were tested in vitro. The effects of histamine on
periostin mRNA and protein levels were evaluated at 2 hours
or 24 hours, respectively, in dermal fibroblasts after histamine
stimulation following preincubation with or without these
histamine receptor antagonists (Figure 3a and b). Histamine-
induced periostin expression was blocked by H1R antagonist
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Figure 1. Collagen production is induced by histamine stimulation in cultured wild-type (WT) fibroblasts. (a) Effect of histamine on collagen type-I alpha 1
(Col1a1) mRNA expression was assessed by quantitative real-time reverse transcriptase–PCR (qRT-PCR) at 12 hours (white bar) and 48 hours (black bar) after
the addition of histamine at the indicated concentration. (b) Effect of histamine on Col1a1 mRNA expression after the stimulation with histamine (100mM)
for the indicated time periods. (c) Soluble collagen content in the supernatants of WT fibroblasts that had been stimulated with histamine for 48 hours.
(d) Representative western blotting and quantitative analyses of signal density on blots from three independent experiments analyzing collagen protein expression
in response to 48 hours of histamine stimulation (using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an internal control). Values were derived from
three independent experiments using WT fibroblast cultures. Values represent the mean±SD for the three independent experiments in each condition. *Po0.05;
***Po0.001; NS, no significance, compared with control (0mM histamine) by one-way analysis of variance (ANOVA) followed by Dunnett’s test.
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but not by either H2R or H4R antagonists (Figure 3a and b),
suggesting that histamine upregulates periostin expression
through H1R activation in vitro.
Next, we determined whether periostin was induced by
histamine via H1R in vivo. Histamine release was triggered
through mast cell degranulation using the compound 48/80
in WT and H1R-deficienct (H1R / ) mice. After treatment
with compound 48/80 for three consecutive days, skin at the
injected site was sampled. Periostin expression in WT and
H1R / mouse skin was compared by western blotting
analyses (Figure 3c). In WT mice, periostin expression mark-
edly increased after compound 48/80 treatment, although no
such increase was observed in H1R / mice (Figure 3c).
These results suggest that H1R mediates histamine-induced
periostin upregulation.
H1R activation upregulates periostin expression via the ERK1/2
pathway
Next, to investigate the signal transduction pathway involved
after H1R activation by histamine in dermal fibroblasts, we
used a commercial human phosphorylated kinase array kit
to profile the phosphorylated kinases in normal human
dermal fibroblasts (Figure 4a). Subsequently, phosphorylation
of analogous kinases was confirmed in murine dermal
fibroblasts by western blot analysis (Figure 4b). Compared
with nontreated dermal fibroblasts, enhanced phosphorylation
of extracellular signal-regulated kinase 1/2 (ERK1/2) and the
downstream factor cAMP response element-binding protein
(CREB) was observed after 10 minutes and 30 minutes of
histamine stimulation (Figure 4a and b).
Furthermore, we found that histamine-induced phosphor-
ylation of ERK1/2 and CREB was blocked not only with U0126
(a selective ERK1/2 kinase inhibitor) but also with an H1R
antagonist (Figure 4c and d).
These observations demonstrated that histamine activates
the ERK1/2 signal transduction pathway via H1R in dermal
fibroblasts.
In addition, to verify the involvement of ERK1/2 activation
in histamine-induced upregulation of periostin, western blot-
ting analysis was performed (Figure 4c and d). Both U0126
and H1R antagonists decreased the expression of periostin, as
well as suppressed the phosphorylation of CREB (Figure 4c
and d). These results indicated that H1R-mediated signaling
upregulated periostin expression via the ERK1/2 pathway.
H1R-mediated upregulation of periostin is essential for
histamine-induced collagen production
To investigate the involvement of periostin in histamine-
induced collagen production, primary dermal fibroblasts from
WT and periostin-deficient (PN / ) mice were stimulated
with histamine (100mM) for 48 hours. The induction of
collagen was abolished in PN / fibroblasts at both the
mRNA (Figure 5a) and protein (Figure 5b and c) levels.
Histamine-treated PN / fibroblasts did not exhibit increases
in mRNA or protein expression of type I collagen (Col1;
Figure 5a–c).
As described above, periostin was induced by histamine via
the H1R pathway. To further clarify whether H1R was
associated with histamine-induced collagen production, H1R
antagonist was added to WT fibroblasts before histamine
stimulation. After 48 hours of histamine stimulation, collagen
production was evaluated as determined by quantitative real-
time reverse transcriptase–PCR, Sircol Collagen Assay, and
western blotting analyses (Figure 6). As expected, histamine-
induced collagen synthesis was blocked by an H1R antagonist
(Figure 6a–c). Furthermore, this inhibitory effect was rescued
by the addition of recombinant mouse periostin (rmPeriostin;
Figure 6a–c).
In addition, this mechanism was confirmed in cultured
primary human dermal fibroblasts derived from healthy donor
skin biopsies (Supplementary Figure S1 online).
Finally, we addressed the question of how strong the effect
of histamine on tissue remodeling was in AD. Compared with
normal skin and AD nonlesioned skin, increased expression of
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Figure 2. Periostin is upregulated upon histamine stimulation in cultured wild-type (WT) fibroblasts. WT fibroblasts were stimulated with histamine at the
indicated concentrations for 2 hours (a, b) or 24 hours (c). Periostin mRNA expression was determined by reverse transcriptase–PCR (RT-PCR) analysis (a) and real-
time PCR analysis (b). Periostin protein expression was evaluated by western blotting analysis (c). Three independent experiments were performed, and
representative blots and quantitative analysis of signal density on blots from three independent experiments are shown (using glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) as an internal control). Values in b and c are shown as mean±SD for three independent experiments. ***Po0.001; NS, no significance,
compared with control (0mM histamine) by one-way analysis of variance (ANOVA) followed by Dunnett’s test.
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periostin was observed in both acute AD lesioned skin and
skin tissues with positive Dermatophagoides farinae (Derf1)
scratch tests (Supplementary Figure S2 online). Our results
suggest that histamine may contribute to the initiation of tissue
remodeling during the acute phase of AD.
DISCUSSION
Here, we report that histamine increases the expression of
periostin in dermal fibroblasts. Moreover, periostin increases
de novo synthesis of Col1 via an ERK1/2-mediated pathway.
It is widely recognized that mast cells contribute to the
healing of skin wounds (Hebda et al., 1993; Artuc et al., 1999;
Trautmann et al., 2000; Gailit et al., 2001; Noli and Miolo,
2001). Impaired wound closure in mast cell–deficient mice
indicates that mast cells have a crucial role in the wound
repair process (Weller et al., 2006). An increased number of
mast cells in fibrotic tissues such as scleroderma, keloid, or
healing wounds has been identified (Hawkins et al., 1985;
Atkins and Clark, 1987), although it is still unclear whether
mast cells are fibrogenic. In many instances, chemical
mediators, such as histamine, which is derived from
degranulated mast cells or basophils, have been implicated
as a cause of inflammation and tissue remodeling in AD
(Davies and Greaves, 1980; Nishioka et al., 1987; Wahlgren,
1999; Murota and Katayama, 2009). In support of these
findings, H1R antagonist has been shown to inhibit the
synthesis of Col1 by dermal fibroblasts (Murota et al., 2008).
Interestingly, histamine H1R antagonists but not H2R anta-
gonists reduced wound closure in experimentally induced skin
wounds in mice (Weller et al., 2006). Therefore, histamine
is believed to have an important role in the wound-healing
process. Indeed, disruption of histamine in histidine
decarboxylase knockout mice resulted in delayed cutaneous
would healing, and this phenotype was rescued by exogenous
histamine administration (Numata et al., 2006). It remains
unclear how histamine promotes wound healing. Some
reports indicated that histamine induces fibroblast prolifera-
tion after a long period of coculturing (Russel et al., 1977;
Topol et al., 1981). In our study, increased expression of Col1
mRNA was observed after 48 hours of co-incubation with
histamine. Thus, histamine-mediated tissue remodeling may
require the expression of periostin as a second messenger in
order to elicit tissue remodeling.
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Figure 3. Histamine upregulates periostin expression via histamine receptor 1
(H1R) in vitro and in vivo. In vitro, wild-type (WT) fibroblasts were either
treated with histamine antagonists (H1R, H2R, or H4R; 100 mM) or left
untreated for 2 hours, and then cells were stimulated with histamine (100mM)
for an additional 2 hours (a) or 24 hours (b). Periostin expression was examined
by quantitative real-time reverse transcriptase–PCR (qRT-PCR) (a) and western
blotting analysis (b). In vivo, WT and H1 / mice were treated with mast cell
stimulator compound 48/80 for 3 days by subcutaneous injection, and
periostin protein expression in the injected site skin was evaluated by western
blotting analysis (n¼4 mice per group); representative blots and quantitative
analysis of signal density on blots from four mice of each group are shown
(using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an internal
control). (c) Values in a and b are shown as mean±SD for three independent
experiments. Values in c are shown as mean±SD for blot signals from four
mice. ***Po0.001; NS, no significance, compared with control (0mM
histamine in a and b; WT-phosphate-buffered saline in c by one-way analysis
of variance (ANOVA) followed by Dunnett’s test.
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Periostin, a recently characterized matricellular protein, has
been reported to have crucial roles in tooth and periodontium
development (Horiuchi et al., 1999), cancer proliferation and
invasion (Siriwardena et al., 2006; Baril et al., 2007; Kudo
et al., 2012), cardiac healing after acute myocardial infarction
(Shimazaki et al., 2008), idiopathic interstitial pneumonia
(Okamoto et al., 2011), and bone marrow fibrosis (Oku
et al., 2008). Furthermore, periostin is highly expressed in
connective tissue and at the remodeling tissue site after injury
or inflammation. This protein is secreted from fibroblasts via
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transforming growth factor beta stimulation (Horiuchi et al.,
1999). Periostin was shown to accelerate cardiac healing
after acute myocardial infarction (Dorn, 2007; Oka et al.,
2007; Shimazaki et al., 2008) and during full-thickness
cutaneous wound repair (Nishiyama et al., 2011; Elliott
et al., 2012; Ontsuka et al., 2012) by modulating fibroblast
differentiation.
Periostin has also been reported to be induced by other
factors, including bone morphogenetic proteins, vascular
endothelial growth factor, connective tissue growth factor,
vitamin K, IL-3, IL-4, IL-6, and IL-13 (Asano et al., 2005;
Takayama et al., 2006; Iekushi et al., 2007; Blanchard et al.,
2008; Coutu et al., 2008; Banerjee et al., 2009; Norris et al.,
2009). Recently, the increased expression of periostin was
confirmed in various allergic diseases such as bronchial
asthma (Takayama et al., 2006), AD (Masuoka et al., 2012),
and eosinophilic chronic rhinosinusitis (Hur et al., 2012). As
an IL-4- and IL-13-inducible protein, periostin is associated
with tissue remodeling in bronchial asthma (Takayama et al.,
2006), allergic eosinophilic esophagitis (Blanchard et al.,
2008), AD (Masuoka et al., 2012), and allergic rhinitis (Hur
et al., 2012). In the present study, histamine was found to
directly induce periostin expression, whereas the expression
levels of transforming growth factor beta, IL-4, and IL-13 were
not altered by histamine stimulation (data not shown). Thus,
we postulate that periostin is involved in the initiation of tissue
remodeling in chronic allergic diseases.
AD is known to develop tissue remodeling, which is
characterized by epidermal thickening, hyperkeratosis and
fibrosis of the papillary dermis, increased fibroblast prolifera-
tion, and collagen accumulation, and these features are
caused by nonspecific stimuli, constant scratching, and rub-
bing (Lee et al., 2009). Tissue remodeling and repair are
thought to be the underlying causes of chronic allergic
inflammation, such as in asthmatic diseases and AD (Leung,
1995). Recently, increased expressions of periostin and the
inducers of periostin (IL-4, IL-13, and transforming growth
factor beta) were identified in a screening of AD-associated
genes in genome-wide association studies and quantitative
mRNA expression analysis in lesion tissues (Hoffjan and
Epplen, 2005; Wood et al., 2009a, 2009b). Furthermore, in
the present study, elevated expression of periostin was found
in lesional skin of patients with AD. These results suggest that
periostin may be involved in AD and in asthma.
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In WT and PN / mice, a mite extract–induced AD model
was established and analyzed. In contrast to WT mice, PN /
mice showed amelioration of epidermal hyperplasia and
inflammatory cell infiltration (Masuoka et al., 2012). Moreover,
periostin directly induces production of thymic stromal
lymphoprotein in keratinocytes (Masuoka et al., 2012). Thus,
periostin was suggested to have a critical role in the
amplification and chronicity of allergic skin inflammation.
The results of the present study demonstrate the role of
periostin in histamine-mediated collagen production. We
found that H1R-mediated phosphorylation of ERK1/2 had a
crucial role in histamine-induced collagen production. These
observations may open a new window of therapeutic oppor-
tunity against airway remodeling in asthma or dermal remo-
deling in AD, as histamine H1R anatagonists are expected to
ameliorate tissue remodeling.
As refractory chronic allergic symptoms are known to
impair the quality of life, work productivity, and overall
activity (Meltzer et al., 1999; Thompson et al., 2000;
Kawashima et al., 2002; Baiardini et al., 2003; Spector
et al., 2007), we believe that these studies will provide a
basis for exploring the fibrotic components of allergic diseases
in skin and other tissues.
MATERIALS AND METHODS
Mice
WT mice (C57BL/6 strain) were purchased from CLEA Japan (Osaka,
Japan). Periostin gene knockout (PN / ) mice (C57BL/6 strain) were
generated as previously described.(Shimazaki and Kudo, 2008)
Histamine receptor 1 gene knockout (H1R / ) mice (C57BL/6
strain) were purchased from Oriental Bio Service (Kyoto, Japan).
Mice were maintained in our pathogen-free animal facility. Animal
care and experimentation were performed in accordance with the
institutional guidelines of the National Institute of Biomedical
Innovation, Osaka, Japan and Osaka University, Osaka, Japan. Six-
week-old male mice were used in all experiments. All experiments
used four mice per group.
Compound 48/80 treatment
Compound 48/80 (Sigma, St Louis, MO) was dissolved in phosphate-
buffered saline at a concentration of 1 mg ml 1 and sterilized by
filtration. With the use of a 27-gauge needle, 100ml of compound
48/80 or phosphate-buffered saline was subcutaneously injected into
the back side of mice each day for 3 days. One day after the final
injection, the skin at the injected site was removed and solubilized at
4 1C in lysis buffer (0.5% sodium deoxycholate, 1% Nonidet P40,
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Figure 6. Histamine receptor 1 (H1R)-mediated upregulation of periostin is
essential in histamine-induced collagen production. Wild-type (WT)
fibroblasts cultured with or without H1R antagonist preincubations were
stimulated with histamine (100mM) alone or in the presence of recombinant
mouse periostin (rmPeriostin, 100 ng/ ml1). The collagen type-I alpha 1
(Col1a1) mRNA level was examined by quantitative real-time reverse
transcriptase–PCR (qRT-PCR) (a), and collagen protein expression was
evaluated by Sircol assay (b) and western blotting analysis; representative blots
and quantitative analysis of signal density on blots from three independent
experiments are shown (using glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) as an internal control) (c). Values are shown as mean±SD for three
independent experiments. ***Po0.001; NS, no significance compared with
control (0mM histamine) according to one-way analysis of variance (ANOVA)
followed by Dunnett’s test.
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0.1% sodium dodecyl sulfate, 100mg ml 1 phenylmethylsulfonyl
fluoride, 1 mM sodium orthovanadate, and protease inhibitor cocktail)
for western blotting analysis.
Cell culture
Murine primary dermal fibroblasts from the skin of four newborn WT
and four newborn PN / mice were isolated and cultured as
previously described (Terao et al., 2010). Human primary dermal
fibroblasts were purchased from DS Pharma Biomedical (Osaka,
Japan). After 24 hours of serum starvation, dermal fibroblasts at
confluence were treated with 0.1 to 100mM histamine (Sigma–
Aldrich, Tokyo, Japan) or 100 ng ml 1 recombinant mouse periostin
(rmPeriostin, R&D Systems, Minneapolis, MN) for the indicated
periods of time before extraction of RNA and protein. Cells were
used at passage three. In each experiment, the obtained fibroblasts
were examined at the same time point and under the same culture
conditions (e.g., cell density, passage, and days after plating). For
inhibition experiments, fibroblasts were preincubated for 2 hours with
specific histamine receptor antagonists (Pyrilamine maleate,
Cimetidine, JNJ7777120, 100 mM, Sigma–Aldrich) or ERK1/2 inhibitor
(U0126, 20mM, Cell Signaling Technology, Beverly, MA) before the
addition of histamine. We performed serial dilutions of each agent to
identify the most effective concentrations to be used in the experi-
ments, as determined by MTT assays and western blotting analyses.
Quantitative real-time and direct reverse transcriptase–PCR
analysis of mRNA
Total RNA was isolated from fibroblasts using the RNeasy Mini Kit
(QIAGEN, Tokyo, Japan) according to the manufacturer’s protocol.
First, 100 ng of RNA was reverse-transcribed using the QuantiTect
Reverse Transcription Kit (QIAGEN). For quantitative real-time
reverse transcriptase–PCR analysis, standard curves for periostin,
collagen, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
were generated from serial dilutions of positively expressing cDNA.
Relative quantification of the PCR products was carried out using the
ABI prism 7000 (Applied Biosystems, Darmstadt, Germany) and the
comparative threshold cycle (CT) method. The ‘‘fold-induction’’ was
calculated as the ratio to values of cells that were not incubated with
histamine or periostin. The primers used for real-time PCR were as
follows: periostin, sense 50-GAACGAATCATTACAGGTCC-30, anti-
sense 50-GGAGACCTCTTTTTGCAAGA-30; collagen type-I alpha 1
(Col1-a1), sense 50-GAGCCCTCGCTTCCGTACTC-30, antisense
50-TGTTCCCTACTCAGCCGTCTGT-30; and GAPDH, sense 50-TGTC
ATCATACTTGGCAGGTTTCT-30, antisense 50-CATGGCCTTCCGTG
TTCCTA-30. Each reaction was performed in triplicate. Variation
within samples was less than 10%. Statistical analysis was performed
with the Student’s paired t-test.
Western blotting analyses
For preparation of protein samples, cell pellets and skin samples were
extracted as described above, and 5mg of extracted protein was used
for western blotting analysis, as described previously (Terao et al.,
2010). The primary antibodies were used at the following dilutions:
anti-type I collagen (Calbiochem, San Diego, CA) at 1:500, anti-
periostin (R&D Systems, Minneapolis, MN) at 1:500, anti-phospho-
ERK1/2 (Cell Signaling Technology) at 1:1,000, anti-total ERK1/2 (Cell
Signaling Technology) at 1:1,000, anti-phospho-CREB (Cell Signaling
Technology) at 1:1,000, anti-total CREB (Cell Signaling Technology)
at 1:1,000, and anti-GAPDH (Santa Cruz Biotechnology, Santa Cruz,
CA) at 1:500. Staining with the anti-GAPDH antibody was used as a
loading control. Signal intensity of bands was quantified using the
ImageJ densitometry software (http://rsb.info.nih.gov/ij/index.html)
and normalized to GAPDH signal intensity.
Sircol collagen assay
The soluble collagen levels in culture supernatants were measured
using a Sircol Collagen Assay (Biocolor, Belfast, UK). This assay
measured total secreted collagen from cultured cells. Briefly, cells
were cultured for 48 hours with or without treatment, and then
supernatants were collected. One milliliter of Sirius red, an anionic
dye that specifically reacts with the basic side chain groups of
collagens, was added to 200ml of the supernatant and incubated
with gentle rotation for 30 minutes at room temperature. After
centrifugation, the collagen-bound dye was resolubilized in 1 ml of
0.5 M NaOH, and the absorbance at 540 nm was measured.
Phosphorylated kinase array
Phosphorylated kinase was profiled with the Proteome Profiler
Human Phospho-Kinase Array Kit (R&D Systems). The procedures
were performed according to the manufacturer’s protocol using
300mg of protein lysate per array.
Statistical analysis
All experiments reported in this paper were repeated at least three
times, yielding similar results, and data are presented as mean±SD.
The Student’s two-tailed t-test (Microsoft Excel software, Redmond,
WA) was used for comparison between two groups. When analysis
included more than two groups, one-way analysis of variance
(ANOVA) followed by Dunnett’s test was used. P-values less than
0.05 were considered statistically significant.
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